Search

everythinglearnresearchcommunity

for

Search:↓

A hormone linked to collagen helps hair grow back in mice after chemotherapy, and may also prevent bone loss.

Adrenocortical carcinoma is a rare, aggressive adrenal gland cancer with a poor outlook.

The document highlights various patents for new compounds with potential treatments for multiple diseases, including cancer, hormonal disorders, and diabetes.

The document suggests that blocking sweat glands with antiperspirants might allow skin-generated hormones to be absorbed, possibly increasing breast and prostate cancer risk.

Breast cancer patients taking CDK4/6 inhibitors are more likely to experience fatigue, hair loss, and mouth sores.

Gene variant linked to prostate cancer, hormone levels, and hair loss.

Early balding at 40 increases prostate cancer risk.

Doxil showed some effectiveness against advanced prostate cancer but caused severe side effects at higher doses.

A49T gene variant linked to higher prostate cancer risk, lower hormone levels, and slightly reduced balding risk.

Parathyroid hormone-related protein helps control hair growth phases in mice.

Steroid sex hormones activate matriptase in prostate cancer cells but not in breast cancer cells.

CDK4/6 inhibitors have improved treatment outcomes for certain advanced breast cancer patients.

Reproductive hormones play a crucial role in breast cancer development and treatment challenges.

Men with a certain baldness pattern at age 40-50 may have a higher risk of aggressive prostate cancer.

Sex hormones, especially estradiol, can change chicken feather shapes and colors.

Testosterone and its byproducts help support male sexual behavior through different pathways in the brain and body.

Men with frontal male pattern baldness may have a higher risk of gastric cancer.

Human skin makes sexual hormones that affect hair growth, skin health, and healing; too much can cause acne and hair loss, while treatments can manage these conditions.

Hair loss gene linked to prostate issues.

Dehydroepiandrosterone (DHEA) is a prohormone important for producing sex steroids and has potential health benefits.

Wedelolactone selectively kills prostate cancer cells without harming normal cells.

Sorafenib helps some advanced cancers alone or with other treatments, but not all, and research continues to improve its use.

2007 research improved understanding of prostate cancer risk, diagnosis, and treatment, but also showed the need for personalized treatment and further study on certain therapies' risks.

Skin side effects from CDK4/6 inhibitors in breast cancer patients are generally mild and treatable, allowing most patients to continue treatment.

Hair loss is a common, often overlooked side effect of hormone treatments for breast and prostate cancer.

In 2007, prostate cancer research improved understanding of risk, diagnosis, and treatment, but also showed heart risks with certain therapies and the need for personalized care.

Androgen therapy can help with symptoms like low libido in women, but more research is needed to understand its long-term safety and effects on health.

The document concludes that sex hormones and related compounds have various effects on health, with both potential benefits and risks.

Testosterone therapy seems safe and effective for transgender men with proper care, but more long-term research is needed.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.